🇺🇸 FDA

Intelligence · Patent portfolio

ALMIRALL S.P.A Patents

Full USPTO pharma patent portfolio for ALMIRALL S.P.A — grant dates, expiration, and drug cross-links.

Patents
308
Expiring ≤24m
14

Quick answer

ALMIRALL S.P.A has 308 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 14 expire within 24 months — use filters for patent-cliff planning.

Page 1 of 7

  1. US 12421253

    Tetrahydropyridopyrimidine pan-KRas inhibitors

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12421228

    Naphthyridine derivatives as PRC2 inhibitors

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12414911

    Topical compositions and methods of use

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12412764

    Substrate-accommodating container

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12398154

    Azaquinazoline pan-KRas inhibitors

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12383503

    Adagrasib solid pharmaceutical compositions

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12377101

    Combination therapies

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12371435

    Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12358892

    Metalloenzyme inhibitors for treating cancers, Alzheimer's disease, hemochromatosis, and other disorders

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12336995

    Combination therapies

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12297509

    Biomarkers for predicting tumor response to and toxicity of immunotherapy

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12290505

    Tissue factor-targeted antibody-drug conjugate

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12286431

    Crystalline forms of a KRas G12C inhibitor

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12280055

    Combination therapies

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 12281113

    Crystalline forms of a KRas G12C inhibitor

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 12280142

    Compositions for preventing infection

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 12252493

    Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 12239684

    Modulators of complement activity

    Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 12208099

    Combination therapies

    Expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 12171765

    Combination therapies using PRMT5 inhibitors for the treatment of cancer

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 12128048

    Combination therapies using PRMT5 inhibitors for the treatment of cancer

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 12109225

    Methods for potentiating cancer treatment using ionizing radiation

    Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 12103978

    Methods and materials for treating cancer

    Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 12012468

    Cyclic polypeptides for PCSK9 inhibition

    Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 12005126

    Compositions for oral administration of pentosan polysulfate in form of nanoparticles with improved intestinal absorption

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11999753

    Tetrahydropyridopyrimidine pan-KRas inhibitors

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11965040

    Modulation of complement activity

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11964989

    KRas G12D inhibitors

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11932633

    KRas G12C inhibitors

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11932705

    Cyclic polypeptides for PCSK9 inhibition

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11890225

    Devices and methods for slurry generation

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11890285

    Combination therapies

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11882920

    Systems, devices and methods for styling hair

    Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11814444

    Cyclic polypeptides for PCSK9 inhibition

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11814445

    Cyclic polypeptides for PCSK9 inhibition

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11795130

    Process for separating a constituent/cannabinoid using a chromatographic resin

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11752190

    Modulators of complement activity

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11723949

    Modulators of complement activity

    Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11707503

    Modulators of complement activity

    Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11642366

    Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and/or chemotherapy

    Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11602515

    Pharmaceutical compositions comprising dimethyl fumarate

    Expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11578371

    Biomarkers for predicting tumor response to and toxicity of immunotherapy

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11548888

    KRas G12C inhibitors

    Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11534495

    Tissue factor-targeted antibody-drug conjugate

    Expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11535650

    Modulation of complement activity

    Expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11530244

    Cyclic polypeptides for PCSK9 inhibition

    Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11505575

    Cyclic polypeptides for PCSK9 inhibition

    Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11492351

    MTA-cooperative PRMT5 inhibitors

    Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does ALMIRALL S.P.A have?

308 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do ALMIRALL S.P.A patents expire?

14 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.